A med-tech executive with a track record in the leadership of business units, management of technology and commercialization teams, identification and establishment of partnerships, and formulation of strategic alliances. Extensive industry experience, including point-of-care and in vitro diagnostics, insulin pump and drug delivery technologies, heart-assist and neurovascular devices, and telecare. Demonstrated ability in integrating technology, clinical, regulatory, manufacturing, and reimbursement factors to develop cross-functional plans and mitigate investment risks.
The consultancy consists of a 3 person team each with over 25 years of industry experience in technology, marketing and regulatory affairs at both tier-one and early stage companies.
At Crescent Biomedical, a med-tech consultancy, I provide due diligence services to investors and product commercialization services to companies. My interface with venture partners and private equity firm representatives supports due diligence objectives in mitigating investment risks through technology and development plan assessments, market and competitive breakdowns, and regulatory and reimbursement analyses. My services to companies support product realization objectives that start with funding presentations and extend to project and resource management, development and manufacturing strategy, partner identification and management, process and regulatory compliance, and manufacturing scale-up.